Clinical Trial Update: A Trial of PTS Via Intratumoral Injection in Patients With Central Air Way NSCLC Severe Obstruction [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating PTS delivered by intratumoral injection for central airway obstruction in non-small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• PTS

Snippet

Sponsor: PTS International Inc. | Conditions: Nsclc | Phase 3 | Status: COMPLETED